seed
Stage
1
Investors
About
Synlogic is a biopharmaceutical company that engineers synthetic probiotic bacteria to develop novel living therapeutics targeting rare metabolic and serious diseases.
Explore Synlogic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.